Abiopharma

🔍 Xu John (Director)

Company: Maison Solutions Inc. (MSS)

Report Date: 2026-04-22

Detailed Transactions and Holdings:

• Acquired 15,000 shares of Class A Common Stock at $0.13 per share (Direct)
  Date: 2026-04-22 | Code: P | equity_swap_involved: 0 | shares_owned_after: 11,819,000.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 8,400 shares of Class A Common Stock at $0.12 per share (Direct)
  Date: 2026-04-22 | Code: P | equity_swap_involved: 0 | shares_owned_after: 11,827,400.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Currently, Golden Tree USA, Inc. ("Golden") owns 100% of Stratton Arms Holding, LLC ("Stratton"), which serves as general partner and holds an 80.95% limited partnership interest in Amsterdam NYC Fund, LP ("Amsterdam"). Stratton holds 10,400,000 shares of Class A Common Stock directly; Amsterdam holds 1,680,000 shares of Class A Common Stock directly. Golden Tree is deemed to beneficially own 11,760,000 shares of Class A Common Stock (10,400,000 shares held by Stratton plus 1,360,000 shares attributable to Stratton's 80.95% interest in Amsterdam). Golden also directly holds 2,240,000 shares of Class B Common Stock, which may be convertible into Class A Common Stock. Mr. Xu owns 100% of Golden and is therefore deemed the indirect beneficial owner of: (i) 11,760,000 shares of Class A Common Stock through the Stratton/Amsterdam structure, (ii) 2,240,000 shares of Class B Common Stock held by Golden, and (iii) 67,400 shares of Class A Common Stock held directly by Mr. Xu personally.